AAIC 2022

Novel hydroxyl dendrimer-based PET tracer [18F]OP-801 detects early-stage neuroinflammation in 5xFAD mouse model with higher sensitivity than TSPO-PET

NF Conference 2022

Hydroxyl Dendrimer Therapeutics Reduce Toxicity in Targeted Delivery to Plexiform Neurofibroma

ARVO 2022

Safety and Tolerability of a Single Subcutaneous Dose of Anti-Angiogenesis Drug to Treat Neovascular Age-related Macular Degeneration (wet AMD) and Diabetic Macular Edema (DME)

WMIC 2021

Development of a novel hydroxyl dendrimer SPECT tracer, 111In-D6-B483, for selective imaging of brain tumors

WMIC 2021

Development of 18F-OP-801: A Novel Hydroxyl Dendrimer PET Tracer for Imaging Maladaptive Inflammation in the Whole Body and Brain

ARVO 2021

Single Subcutaneous (or Oral) Dose of Anti-Angiogenesis Drug Safely Suppresses Choroidal Neovascularization Comparable to Intravitreal Aflibercept

AASLD 2020

Hepatocyte Targeted Therapy to Enhance Efficacy and Safety of Drugs for Liver Diseases

ACR 2020

Systemic Administration of Novel Hydroxyl Dendrimers to Target Inflammation in Arthritic Tissues

AAIC 2020

Selective targeting of Plaque Associated Microglia through systemic dendrimer administration in an Alzheimer’s disease model